Overview
James Jin is an Oncologist practicing medicine in Elkhart, Indiana.
Dr. Jin is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.
He is actively involved in clinical research, co-authoring 2 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- OTHER MEDICARE
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2117 W Lexington Ave, Elkhart, IN 46514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Michiana Hematology-Oncology P C
Bilal Ansari is an Oncologist practicing medicine in Mishawaka, Indiana. Dr. Ansari is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Childhood Iron Deficiency Anemia.
Michiana Hematology-Oncology P C
Rolan Pascual is an Oncologist practicing medicine in Mishawaka, Indiana. Dr. Pascual is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, Lung Cancer, and Colorectal Cancer.
UChicago Medicine Cancer Care Center At Valparaiso
Ebenezer Kio is a Hematologist and an Oncologist practicing medicine in Valparaiso, Indiana. Dr. Kio is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Hodgkin Lymphoma, and Chronic Lymphocytic Leukemia (CLL).
Frequently Asked Questions about Dr. James Jin
How do I make an appointment with Dr. James Jin?
You can book an appointment with Dr. James Jin by calling their office at 574-296-3444. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. James Jin a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. James Jin is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. James Jin specialize in?
While Dr. James Jin is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. James Jin participate in research or clinical trials?
Yes. Dr. James Jin has published 2 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. James Jin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. James Jin accept my insurance?
Dr. James Jin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 574-296-3444 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Inflammatory Breast CancerDr. Jin isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Jin isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Jin isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Jin isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- AgranulocytosisDr. Jin isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Jin isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Jin isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Breast CancerDr. Jin isAdvanced. Learn about Breast Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Jin isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Jin isExperienced. Learn about Bladder Cancer.
- Brain TumorDr. Jin isExperienced. Learn about Brain Tumor.
- Chromophobe Renal Cell CarcinomaDr. Jin isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Classical Hodgkin LymphomaDr. Jin isExperienced. Learn about Classical Hodgkin Lymphoma.
- Clear Cell SarcomaDr. Jin isExperienced. Learn about Clear Cell Sarcoma.